Tag: Rahul Kakkar

Pandion bags $795m deal with Astellas for pancreas-targeted immunomodulators

pharmanewsdaily- November 2, 2019

Pandion Therapeutics has bagged a $795 million worth license and collaboration deal with Japanese pharma company Astellas Pharma for the research, development, and commercialization of ... Read More